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Abstract: 
Although replacement of dietary saturated fat with monounsaturated and polyunsaturated fatty 
acids (MUFA and PUFA) has been advocated for the reduction of cardiovascular disease risk, 
diets high in PUFA could increase low density lipoprotein (LDL) susceptibility to oxidation, 
potentially contributing to the pathology of atherosclerosis. To investigate this possibility, 15 
postmenopausal women in a blinded crossover trial consumed 15 g of sunflower oil (SU) 
providing 12.3 g/day of oleate, safflower oil (SA) providing 10.5 g/day of linoleate, and fish oil 
(FO) providing 2.0 g/day of eicosapentaenoate (EPA) and 1.4 g/day of docosahexaenoate 
(DHA). During CuSO4- mediated oxidation, LDL was depleted of ot-tocopherol more rapidly 
after FO supplementation than after supplementation with SU (P = 0.0001) and SA (P = 0.05). In 
LDL phospholipid and cholesteryl ester fractions, loss of n-3 PUFA was greater and loss of n-6 
PUFA less after FO supplementation than after SU and SA supplementation (P < 0.05 for all), 
but loss of total PUFA did not differ. The lag phase for phosphatidylcholine hydroperoxide 
(PCOOH) formation was shorter after FO supplementation than after supplementation with SU 
(P = 0.0001) and SA (P = 0.006), whereas the lag phase for cholesteryl linoleate hydroperoxide 
(CE18:2OOH) formation was shorter after FO supplementation than after SU (P = 0.03) but not 
SA. In contrast, maximal rates of PCOOH and CE18:2OOH formation were lower after FO 
supplementation than after SA (P = 0.02 and 0.0001, respectively) and maximal concentrations 
of PCOOH and CE18:2OOH were lower after FO supplementation than after SA (P = 0.03 and 
0.0006, respectively). Taken together, our results suggest that FO supplementation does not 
increase the overall oxidation of LDL ex vivo, especially when compared with SA supplemen-
tation. Consequently, health benefits related to increased fish consumption may not be offset by 
increased LDL oxidative susceptibility.—Higdon, J. V., S. H. Du, Y. S. Lee, T. Wu, and R. C. 
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Article: 
A large body of research supports the hypothesis that the oxidation of low density lipoproteins 
(LDL) in vessel walls plays a significant role in the development of atherosclerosis (1, 2). For 
this reason, factors that influence the oxidative susceptibility of LDL have been the subject of a 
number of investigations. Despite the favorable effects of diets relatively high in unsaturated fat 
on lipid profiles (3, 4), concern exists that such diets could increase the oxidative susceptibility 
of LDL, thereby negating some of their cardioprotective effects. 
 
Generally, the more double bonds present in an unsaturated fatty acid (FA), the more readily it is 
assumed to oxidize in biological systems. These assumptions are based on the results of 
investigations of the in vitro oxidation of unsaturated FAs in homogeneous systems (5). 
However, studies of multiphase systems in vitro (6, 7), which appear to have more similarities to 
LDL than do homogeneous systems, suggest that oxidative susceptibility may not be directly 
related to the degree of unsaturation of a FA. 
 
Studies that have examined the effect of consuming specific unsaturated FAs on the oxidative 
susceptibility of LDL have not resulted in clear support of the notion that the higher the degree 
of unsaturation of dietary polyunsaturated fatty acid (PUFA), the greater the susceptibility of 
LDL to oxidation. Although a number of studies have demonstrated that diets high in oleate 
(18:1n-9) result in LDL that are more resistant to ex vivo oxidation than diets high in linoleate 
(18:2n-6) (8–10), the effects of increased consumption of the n-3 FAs, eicosapentaenoate (EPA; 
20:5n-3) and docosahexaenoate (DHA; 22:6n-3), on LDL oxidative susceptibility have been 
contradictory. Some studies have suggested that increased dietary intake of EPA and DHA in-
creased LDL susceptibility to ex vivo oxidation (11– 14), while others have found that increasing 
dietary EPA and DHA intake did not increase the oxidative susceptibility of LDL (15–19). The 
contradictory nature of these studies may be related to the assays of LDL oxidation as well as the 
criteria chosen to indicate LDL oxidative susceptibility. For example, shortened lag phase during 
the conjugated diene assay might be the criterion for increased oxidative susceptibility in one 
investigation, whereas increased rate or extent of oxidation might be used as the criterion in 
another investigation. Fish oil (FO) supplementation has been found to shorten lag time as well 
as, paradoxically, to decrease the rate and extent of oxidation in a number of LDL oxidation 
studies employing the conjugated diene assay (14, 19, 20). 
Because LDL oxidation appears to play an important role in the pathobiology of atherosclerosis, 
it is important to assess the effect of increasing dietary unsaturated fatty acids on the oxidative 
susceptibility of LDL. These issues are of particular relevance to postmenopausal women, for 
whom cardiovascular disease is the major cause of mortality in the United States (21). To 
evaluate the effects of specific dietary unsaturated FAs on LDL oxidative susceptibility, we 
isolated LDL from the plasma of postmenopausal women taking daily supplements rich in oleate 
from sunflower oil (SU), linoleate from safflower oil (SA), and EPA and DHA from FO. We 
evaluated the oxidative susceptibility of LDL by monitoring the loss of specific FAs, the loss of 
a-tocopherol, and the formation of phosphatidylcholine hydroperoxides (PCOOH) and cho-
lesteryl ester hydroperoxides (CEOOH) during copper- mediated oxidation. 
To measure lipid hydroperoxides, we used a highly sensitive and specific high performance 
liquid chromatography (HPLC) /chemiluminescence technique that has several advantages over 
the conjugated diene assay often used to evaluate LDL oxidative susceptibility. Although the 
conjugated diene assay provides a measure of overall LDL oxidation, it is not specific for lipid 
classes and it cannot be used to monitor the oxidation of specific fatty acids. 
HPLC/chemiluminescence methods can be used to evaluate LDL surface and core lipid 
peroxidation by monitoring the formation of PCOOH and CEOOH, respectively, in addition to 
allowing for the identification of CEOOH derived from specific FAs (22). 
 
SUBJECTS AND METHODS  
Experiment design 
To assess the effects of each of three oil supplements on individual subjects, a three-period, 
three-treatment, blinded crossover trial was used. During each treatment period, subjects con-
sumed 15 g/day of high oleate SU, high linoleate SA, or FO rich in EPA and DHA. Each 
treatment period lasted 5 weeks and was followed by a 7-week washout interval to minimize any 
carryover effect from the previous treatment. The initial 16 subjects were randomly assigned to 
one of six treatment sequences, resulting in at least two individuals taking supplements in each of 
all possible sequences, each period. The crossover trial was also designed to avoid confounding 
of period and treatment effects by including each treatment in each period. This design allowed 
for the statistical assessment of carryover effects, described in the statistical analysis section 
(23). Total time of participation in the study was 29 weeks. 
 
Blood samples were taken on two separate mornings during the 3 days prior to the start of the 
treatment and on two separate mornings during the last 3 days of the 5-week treatment period. 
Compliance was assessed by counting leftover capsules and by evaluating changes in specific 
FA concentrations in plasma FA profiles. 
 
Subjects 
Sixteen postmenopausal women, between 50 and 75 years of age, were recruited from the 
Oregon State University campus and the surrounding community. The criteria for inclusion in 
the study and characteristics of the subjects have been discussed previously (24). The study 
protocol was reviewed and approved by the institutional review board at Oregon State 
University, and written consent was obtained from each subject prior to beginning the study. 
Because one subject dropped out after the first period for reasons unrelated to the study, only the 
data obtained from the other 15 subjects are included in the results. 
 
After the subjects were instructed in the technique of recording all foods and beverages 
consumed over 3 days (2 weekdays and 1 weekend day), they kept 3-day diet records during 
each of the three treatment periods. The nutritional content of each subject’s diet during each 
treatment period was analyzed with the computer software, Food Processor Plus (Version 6.0; 
ESHA, Salem, OR). 
 
Supplements 
The FO used in the treatment was obtained from the National Institute of Health’s Fish Oil Test 
Material Program in sealed opaque containers, containing 100 1-g capsules. The SU (generously 
donated by Humpco, Memphis, TN) and the SA (Arista Industries, Darien, CT) were supplied in 
bulk and encapsulated (Professional Compounding Pharmacy, Corvallis, OR) after adjusting 
their antioxidant content to be equivalent to that of FO. Concentrations of α- and γ-tocopherol in 
the supplemental oils were measured by normal-phase HPLC, using fluorometric detection 
(excitation λ 292; emission λ 330) based on a standardized method published by the International 
Union of Pure and Applied Chemistry (25). After the adjustment, the daily dose of 15 g of each 
oil supplement supplied approximately 18 mg of RRR-α-tocopherol and 19.5 mg of γ-tocopherol 
or 20 mg α-tocopherol equivalents (α-TE). Neither the p-anisidine value (26) nor the peroxide 
value (27), measures of lipid peroxidation, increased in any of the supplements by the final 
period of the study. We have previously shown that storing the capsules under conditions similar 
to those under in which the subjects stored them did not increase peroxidation (19). FA profiles 
of the supplemental oils were measured by gas chromatography (GC) (28). 
 
Blood collection 
Blood samples were collected from an antecubital vein into tubes containing Na2EDTA (1g/l) 
after an overnight fast of approximately 12 h. Plasma samples were prepared within 1 hour of 
blood collection by centrifugation (600 g) for 15 min at 4°C, using a TJ-6 desktop centrifuge 
(Beckman; Palo Alto, CA). Blood samples were kept in the dark and on ice until centrifugation. 
 
Plasma lipid and lipoprotein profiles 
Plasma total cholesterol concentrations were determined enzymatically, using a modification of 
the method of Allain et al. (29). The cholesterol assay met the National Cholesterol Education 
Program’s performance criteria for accuracy. Plasma triacylglycerol (TG) concentrations were 
measured using a modification of the method of McGowan et al. (30). High density lipoprotein 
(HDL) cholesterol concentrations were measured enzymatically after precipitation of LDL and 
very low density lipoprotein (VLDL) fractions with phosphotungstic acid and MgCl2 (31). LDL 
cholesterol concentrations were calculated using the formula of Friedewald (32). 
 
LDL isolation and preparation 
Immediately after plasma was separated from red cells, LDL was isolated by single spin 
discontinuous density gradient ultra- centrifugation as described by Chung et al. (33). Briefly, 
plasma density was adjusted to 1.30 g/ml by adding solid KBr and carefully layered under 0.9% 
saline in a Quick-seal centrifuge tube (Cat. No. 34413, Beckman). Sealed tubes were centrifuged 
with a near vertical rotor (NVT 65, Beckman) at 60,000 rpm for 120 min in an L5-75 
ultracentrifuge (Beckman) at 7°C. Immediately after isolation, samples for LDL composition 
were capped with argon and frozen at —70°C, whereas samples for LDL oxidation were 
dialyzed against phosphate-buffered saline (PBS; 0.15 M NaCl, 0.01 M NaH2PO4, pH 7.4) in the 
dark at 4°C to remove EDTA. The PBS was degassed for 10 min with a water aspirator and 
purged with nitrogen for 5 min prior to use in order to remove oxygen from the solution. The 
buffer (LDL/PBS; 1:100 v/v) was changed four times during the 20-h dialysis period. 
 
The protein content of LDL was measured using the method of Lowry et al. (34). After dialysis, 
each LDL sample was diluted to a concentration of 0.5 mg LDL protein/ml and oxidized using 
4.69 µM CuSO4 at 37°C. Aliquots removed just prior to the addition of CuSO4 were designated 
as samples taken at 0 min of oxidation. Aliquots of LDL were removed at predetermined time 
points during oxidation for measurement of α-tocopherol, CEOOH, PCOOH, and LDL FA 
profiles. Oxidation was terminated by adding EDTA at a concentration of 1.5 mg/ml and placing 
the samples on ice. 
 
LDL composition by major lipid class 
LDL total cholesterol (TC) concentrations were measured enzymatically using a modification of 
the method of Allain et al. (29), whereas LDL TG concentrations were measured using a 
modification of the method of McGowan et al. (30) (Sigma; St. Louis, MO). LDL free 
cholesterol (FC) and LDL phospholipid (PL) concentrations were also measured using enzymatic 
methods (Wako; Richmond, VA). LDL PLs consist of 62–66% phosphatidyl choline, 24– 28% 
sphingomyelin, 7–7.4% lysophosphatidylcholine, and 2.3% other (2). The enzymatic assay for 
PL in LDL measured cholinecontaining PLs, accounting for 98% of the PLs in LDL. LDL cho-
lesteryl ester (CE) concentrations were calculated as (TC – FC) X 1.68 (35). Assays for LDL 
composition were performed at the end of each of the three treatment periods. The interassay 
coefficient of variation (CV) for TC, TG, FC, and PL between treatment periods were 3.0%, 
5.7%, 9.4%, and 3.6%, respectively. 
 
FA profiles of LDL PLs and CEs 
The FA profiles of LDL lipids were analyzed at 0 and 360 min of CuSO4-mediated oxidation. 
LDL lipids were extracted using a modification of the method of Bligh and Dryer (36). Internal 
standards of diheptadecanoyl phoshatidylcholine (PC17:0) and cholesterol heptadecanoate 
(CE17:0) were added to each LDL sample prior to extraction. Lipids were separated using 20 X 
20 cm Silica-Gel thin-layer chromatography (TLC) plates (Alltech; Deerfield, IL). Separation of 
the lipid classes was achieved by elution with diethylether-hexane (15:85, v/v). CE and PL bands 
were identified by comparison with authentic standards applied to the same TLC plate as the 
samples (37). Bands corresponding to CE and PL fractions were methylated in the presence of 
heneicosanoic methyl ester (methyl 21:0) as a standard, and analyzed using GC as described 
previously (28). Losses of individual LDL FAs were calculated by subtracting the concentration 
at 360 min of oxidation from the concentration at 0 min. The peroxidation index (PI) is an 
estimate of the concentration of bisallylic hydrogen atoms present in unsaturated FAs, and may 
therefore be viewed as an index of their susceptibility to oxidation. The PI was calculated as 
follows: PI = (YPUFA with 2 double bonds X 1) + (YPUFA with 3 double bonds X 2) + 
(YPUFA with 4 double bonds X 3) + (YPUFA with 5 double bonds X 4) + (YPUFA with 6 
double bonds X 5). 
 
LDL α-tocopherol concentration 
LDL α-tocopherol concentrations were measured by reverse- phase HPLC with fluorometric 
detection (excitation X 292 nm, emission X 330 nm), using external standards of pure α-tocoph-
erol (Sigma) of known concentration (38). Recovery of added α-tocopherol to LDL samples 
averaged 92% and the interassay CV was 5.6%. The α-tocopherol was extracted from LDL and 
measured immediately after CuSO4 -mediated oxidation was terminated by the addition of 
EDTA. LDL α-tocopherol concentrations were compared among the three supplement groups 
before oxidation and after 10 and 20 min of oxidation. Because the rate of α-tocopherol loss was 
nearly linear in the majority of cases, the rate of α-tocopherol loss was calculated as the slope of 
the line of best fit between the three time points. The intercept of the same line with the time axis 
was used to estimate the time of α-tocopherol depletion of LDL during oxidation. LDL α-to-
copherol concentrations were normalized to LDL protein and to LDL lipid content (the sum of 
the molar concentrations of TC, TG, and PL in LDL). 
PC and CE hydroperoxides in LDL 
PCOOH and CEOOH were measured in LDL at 0, 20, 40, 60, 90, 120, 180, 240, 300, and 360 
min of CuSO4-mediated oxidation using HPLC with postcolumn chemiluminescence detection, 
based on the methods of Sattler, Mohr, and Stocker (39). These methods have been demonstrated 
to be highly sensitive and specific for PCOOH and CEOOH (22). 
 
To remove traces of contaminating metals, Chelex 100 resin (Bio-Rad; Richmond, CA) was 
added to all aqueous buffers. HPLC solvents were stored in dark bottles at 4°C over a 4 Å mo-
lecular sieve (~100 g/l, Aldrich; Milwaukee, WI) to deplete them of hydroperoxides. Hexane was 
washed to remove trace amounts of hydroperoxides (40). 
 
Lipid hydroperoxides of unoxidized and oxidized LDL were extracted into methanol (PCOOH) 
and washed hexane (CEOOH). To measure PCOOH, the aqueous methanol extract was filtered 
and injected onto a NH2 column (LC-NH2, 5µ, 250 X 4.6 mm, Supelco; Bellefonte, PA), using 
methanol/40 mM NaH2PO4 95:5 (v/v) as a mobile phase, at a flow rate of 1.0 ml/ min. A 
postcolumn chemiluminescence reagent consisting of 1:1 (v/v) methanol/100 mM sodium borate 
buffer (pH 10) containing 1 mM isoluminol (6-amino-2,3,-dihydro-1,4-phthalazinedione; Sigma) 
and 3 mg/l microperoxidase (MP-11; Sigma), at a flow rate of 1.5 ml/min, was added to the 
eluent. The reaction of hydroperoxides and the postcolumn reagent resulted in the generation of 
light, which was quantified using a chemiluminescence detector (S-3400, Soma Optics, Japan). 
 
The identification standard for PCOOH was prepared by oxidation of 20 mg of soybean PC 
(Sigma) in 1 ml of methanol and 2 mM 2,2'-azobis(2-methylpropionitrile) (AIBN; Aldrich) at 
37°C for 6 h. Fifteen(S)-hydroperoxyeicosatetraenoic acid [15(S)-HPETE; #44720, Cayman 
Chemicals, Ann Arbor, MI] was used as an external quantification standard. The lower level of 
detection of PCOOH was approximately 50-pmol/mg LDL protein, and the interassay CV was 
8.3%. PCOOH were extracted from LDL immediately after CuSO4-mediated oxidation was ter-
minated by the addition of EDTA. Extracted samples were capped with argon and immediately 
frozen at —80° C. They were assayed within 4 weeks of collection. 
 
To measure CEOOH, the hexane extract was evaporated under nitrogen and concentrated in 
ethanol. Twenty to 100 µl were injected onto a C-18 column (Shim-pack CLS-ODS 5 µ, 250 X 
4.6 mm, Shimadzu; Columbia, MD) using a mobile phase of methanol-tert-butanol 3:1 (v/v) at a 
flow rate of 1 ml/min. The postcolumn chemiluminescence reagent was the same as that used in 
the PCOOH assay at a flow rate of 1.5 ml/min. CEOOH concentrations were quantified using 
15(S)-HPETE as an external standard. External standards for the identification of the hydroper-
oxides of CE18:1n-9 (CE18:1OOH), CE18:2n-6 (CE18:2OOH), CE20:4n-6 (CE20:4OOH), 
CE20:5n-3 (CE20:5OOH), and CE22:6n-3 (CE22:6OOH) were prepared separately by the oxi-
dation of 20 mg of the pure CE (NuChek Prep, Elysian, MN) in 1 ml of toluene and 2 mM 
AIBN at 37°C for 6 h. After evaporation of the toluene under nitrogen, the oxidized CE was 
resuspended in 1 ml of hexane and applied to a hexane-preconditioned Al2O3 solid-phase 
extraction column (Supelclean Alumina N; Supelco). The unoxidized CE was eluted with hex-
ane and the CEOOH was eluted with tert-butylmethyl ether. Purified CEOOH standards were 
assayed individually using the HPLC chemiluminescence procedure described in the previous 
paragraph. A combination of all five CEOOH standards was used to evaluate the separation of 
different species of CEOOH from one another. 
 
The lower level of detection for CE18:2OOH was approximately 10-pmol/mg LDL protein, and 
the interassay CV was 4.2%. CEOOH were extracted from LDL immediately after CuSO4 -
mediated oxidation was terminated by the addition of EDTA. Extracted samples were capped 
with argon and immediately frozen at —80°C, and were measured within 6 days of collection. 
 
Hydroperoxide concentrations were plotted over time of CuSO4 -mediated oxidation for 
CEOOH and PCOOH separately. Maximal rate was determined to be the slope of the line of 
best fit, using the method of least squares, through the points that defined the steepest slope of 
the curve. The length of the lag phase was determined to be the time (value for x) at the 
intersection of the line describing the maximal rate and the line describing the initial rate. The 
maximal concentration was taken to be the maximal concentration measured during 6 h of 
oxidation, and the time to one-half of the maximal concentration was determined by drawing a 
perpendicular line from the oxidation curve at one half the value of the maximal concentration 
(y axis) to the time (x) axis (41). 
Statistical analysis 
A 7-week washout period was utilized after each treatment period to decrease the likelihood of 
carryover effects. Balanced random assignment of at least two subjects to all six possible 
treatment sequences allowed for the statistical assessment of carryover effects prior to inference 
regarding direct treatment effects. Carryover effects were estimated and direct treatment effects 
analyzed, utilizing a combination of between- and within-subjects analysis of variance 
(ANOVA) procedures as described by Kuehl (23). Briefly, the between-subjects sources of 
variation consisted of 1) sequence of treatment and 2) subjects nested within sequence; the 
within-subjects sources of variation consisted of 1) period, 2) treatment (direct), and 3) 
treatment (carryover). If treatment carryover effects were significant (P < 0.05), estimates of 
differences among treatment means could be adjusted for the carryover effects. If carryover 
effects were not found to be statistically significant, the ANOVA was performed without the 
treatment (carryover) effect in the model. No significant treatment carryover effects were found 
for any of the data presented. Therefore, all least square means (LSM) presented represent direct 
treatment effects. Because no significant period-treatment interactions were encountered, the 
period-treatment interaction was not included in the final model. If the ANOVA demonstrated a 
significant treatment effect, P values for the differences between LSM were adjusted for 
multiple comparisons using Tukey’s studentized range test. Results with P values < 0.05 for a 
two-sided test were considered statistically significant. Analyses were accomplished using the 
SAS general linear model (GLM) procedure (Version 6.12; SAS Institute Inc., Cary, NC). 
 
RESULTS 
Subject characteristics 
All subjects were postmenopausal and taking hormone replacement therapy (HRT). Each subject 
continued her regimen of HRT, without alteration, for the duration of the study. Although the 
women’s HRT regimens were not identical, they were generally equivalent to 0.625 mg con-
jugated estrogens daily for hysterectomized women and 0.625 mg conjugated estrogens plus 2.5 
mg medroxyprogesterone daily for women who had not had hysterectomies. The subjects did not 
take any chronic prescription medications other than HRT, nor did they take any nutritional 
supplements other than calcium or vitamin D for the duration of the study. Compliance with the 
supplement regimen was estimated to be approximately 95%, based on the return of empty 
supplement containers and leftover supplement capsules. The results of the plasma FA profiles 
for each subject during each treatment period were also consistent with a high level of 
compliance. 
 
Mean age of the subjects (Table 1) was 58 years (range 52–73 years). Although the mean body 
mass index (BMI) of 25.8 was slightly greater than the desirable upper limit of 24.9, it was well 
under 30, the level at which morbidity and mortality associated with obesity has been found to 
increase rapidly (42). All subjects were found to be normolipidemic on the basis of their lipid 
and lipoprotein profiles (43). The mean weight gain for the participants over the 9-month 
duration of the study was 0.6 kg. 
 
Dietary content of selected nutrients 
Not including the supplements, the subjects consumed an average of 29% of their energy as fat 
(Table 2), with approximately 12% of that energy as saturated fat, 11% as 
TABLE 1. Subject characteristics (N = 15) 
 Norma
l 
Range
°
 
Mean ± SD 
Age (years) 
— 57.6 ± 5.8 
BMI (kg/m
2
) <25 25.8 ± 3.5 
Plasma cholesterol (mmol/l) <6.20 5.23 ± 0.55 
LDL cholesterol (mmol/l) <4.10 2.98 ± 0.61 
HDL cholesterol (mmol/l) >0.90 1.57 ± 0.39 
Plasma triacylglycerol 
(mmol/l) 
<2.30 1.49 ± 0.47 
 
°BMI a25 may indicate obesity (42). Normal ranges for blood lipid concentrations are based on the 
recommendations of the National Cholesterol Education Program (43). 
monounsaturated fat, and 6% as polyunsaturated fat. Of the antioxidant nutrients, mean vitamin 
E intake was 6 mg α-tocopherol equivalents (α-TE)/day, estimated to be 4.8 mg α-tocopherol 
daily using the formula: mg α-tocopherol in food = mg α-TE X 0.8 (44). Thus, dietary α-
tocopherol intake was considerably below the recently revised recommended dietary allowance 
of 15 mg/day of α-tocopherol. Mean vitamin C (138 mg/day) and selenium (57 pg/day) intake 
met recommended levels of 75 mg/day and 55 pg/day, respectively (44). 
A FA profile of each of the supplements is presented in Table 3. The daily intakes of seven FAs 
of interest, from the oil supplements alone and in combination with the subjects’ diets, are 
presented in Table 4. By design, each oil supplement supplied concentrations of specific FAs that 
were high but attainable through dietary manipulation. Fifteen g/day of SU provided 12.3 g/day 
of oleate, whereas 15 g of SA provided 10.5 g/day of linoleate. The same quantity of FO 
provided 2.0 g/day of EPA and 1.4 g/day of DHA. 
As a result of the oil supplements, the total dietary intake of specific FAs differed significantly 
among supplement groups. During the SU supplementation, total 18:1n-9 intake was 11.4 g/day 
higher than during the SA supplementation (P < 0.0001) and 9.7 g/day higher than during the FO 
supplementation (P < 0.0001). During the SA supplementation, 18:2n-6 intake was 9.9 g/day 
higher than during the SU supplementation (P < 0.0001) and 
TABLE 2. Average daily intake of selected nutrients from  
three 3-day diet records° (N = 15) 
 
  
TABLE 3.Selected FAs supplied by each oil supplement 
in mg/g of oil
° 
Fatty Acid Sunflower  
Oil 
Safflower  
Oil 
Fish 
Oil 
14:0 NDb 1.3 79.1 
16:0 32.7 69.3 144.0 
18:0 35.3 24.0 26.3 
20:0 3.2 3.3 4.3 
Y.SFA
c
 84.0 102.0 267.1 
16:1n-7 1.3 122.7 89.4 
c-18:1n-9 818.0 697.3 50.6 
18:1n-7 ND 10.0 24.4 
20:1n-9 2.7 2.0 7.7 
Y.MUFA
d
 821.3 136.0 187.0 
c,c-18:2n-6 38.7 697.3 14.3 
18:3n-3 1.3 1.3 9.7 
20:4n-6 ND ND 7.7 
20:5n-3 ND 1.3 131.1 
22:5n-3 ND ND 23.4 
22:6n-3 ND ND 96.1 
Y.PUFA
e
 39.3 699.3 392.7 
° Values for SU and SA are mean values of samples measured in duplicate. Values for FO were provided 
by the National Institutes of Health Fish Oil Test Materials Program. 
b Not detected. 
c
Sum of the saturated fatty acids = 13:0 + 14:0 + 15:0 + 16:0 + 
18:0 + 19:0 + 20:0 + 21:0 + 22:0 + 23:0 + 24:0. 
d
 Sum of the MUFAs = 16:1n-7 + t-18:1n-9 + c-18:1n-9 + 18:1n-7 + 20:1n-9 + 24:1. 
e
Sum of the PUFAs = t,t-18:2(n-6) + c,c-18:2(n-6) + 18:3(n-3) + 18:4(n-3) + 20:2(n-6) + 20:3(n-6) + 20:3(n-
3) + 20:4(n-6) + 20:5(n-3) + 22:5(n-3) + 22:6(n-3). 
9.1 g/day higher than during the FO supplementation (P < 0.0001). Because the subjects were 
asked to exclude fish from their diets throughout the study, the FO supplement greatly increased 
(approximately 50- to 100-fold) the 20:5n-3 and 22:6n-3 content of the diet when compared with 
the SU and the SA supplements (P < 0.0001 for all four comparisons). During the FO 
supplementation, 20:5n-3 intake was 1.96 and 1.94 g/day higher than during the SU and SA 
supplementations, respectively, and 22:n-6 intake was 1.45 and 1.94 g/day higher than during the 
SU and SA supplementations, respectively. Although total intake of 20:4n-6 was relatively low 
during all three supplementations, it was significantly higher during the FO supplementation (P < 
0.0001) owing to the higher 20:4n-6 content of the FO. 
 
LDL composition by lipid class 
LDL triacylglycerol content after FO supplementation (0.34 ± 0.03 pmol/mg LDL protein) was 
31 % lower than after SU supplementation (0.49 ± 0.05; P = 0.003), although it did not differ 
significantly between the SU and SA (0.43 ± 0.03) and the FO and SA supplementation groups. 
LDL PL content was 5% higher after SA supplementation (1.01 ± 0.02 pmol/mg LDL protein) 
than after SU supplementation (0.96 ± 0.02; P = 0.03) and 6% higher than after FO 
supplementation (0.95 ± 0.02; P = 0.02), whereas LDL PL content did not differ significantly 
between the SU and FO supplementation groups. LDL CE and FC content did not differ 
significantly among the supplementation groups (data not shown). 
 
TABLE 4. Consumption of selected FAs derived from oil supplement and total consumption (oil  
supplement + dietary content) in g/day during each supplement period
°
 (N = 15) 
Fatty Acid  Sunflower Oil  Safflower Oil  Fish Oil 
Oil Diet + Oil Oil Diet + Oil Oil Diet + Oil 
16:0 0.49° 7.70 ± 0.57
b
 1.04 8.32 ± 1.25 2.16 9.65 ± 1.03 
18:0 0.53 3.99 ± 0.33 0.36 3.67 ± 0.54 0.39 3.69 ± 0.47 
c-18:1 n-9 12.27 25.74 ± 1.20
1
 1.84 14.35 ± 2.00
2
 0.76 16.03 ± 
2.032 c,c-18:2 n-
6 
0.58 6.79 ± 0.90
1
 10.46 16.70 ± 1.06
2
 0.22 7.62 ± 1.371 
20:4 n-6 NDc 0.05 ± 0.01
1
 ND 0.07 ± 0.01
1
 0.12 0.17 ± 0.01
2
 
20:5 n-3 ND 0.01 ± 0.01
1
 0.02 0.03 ± 0.02
1
 1.97 1.97 ± 0.012 
22:6 n-3 ND 0.01 ± 0.01
1
 ND 0.03 ± 0.02
1
 1.44 1.46 ± 0.012 
° Values for oil represent measurements made in duplicate; calculations based on 15 g of 
oil/day. 
b Values for diet + oil represent LSM ± SEM. Different superscript numbers 
represent significant differences in total (diet + oil) fatty acid consumption among 
oil supplement groups (P < 0.05). 
c ND = not detected. 
PUFA content of LDL PLs prior to and after 6 h of oxidation 
At the end of each supplement period, the FA content of LDL PLs prior to oxidation generally 
reflected the differences in FA consumption (Table 5). After SU supplementation, LDL PLs 
contained 37 nmol/mg LDL protein more 18:1n-9 than after SA supplementation (P < 0.0001) 
and 45 nmol/mg LDL protein more 18:1n-9 than after FO supplementation (P < 0.0001). After 
FO supplementation, LDL PLs contained 45-nmol/mg LDL protein less 18:2n-6 than after SU 
supplementation (P = 0.01) and 61 nmol/mg LDL protein less 18:2n-6 than after SA supple-
mentation (P < 0.0001). After FO supplementation, LDL PLs contained approximately 52 
nmol/mg LDL protein more 20:5n-3 than after SU and SA supplementation, and approximately 
33 nmol/mg LDL protein more 22:6n-3 than after SU and SA supplementation (P < 0.0001 for 
all four comparisons). After FO supplementation, the PI was 40% higher than after SU or SA 
supplementation (P < 0.0001 for both comparisons). 
 
Losses of specific FAs from LDL PLs after 6 h of CuSO4- mediated oxidation, determined as 
the difference between the concentration of a given FA prior to oxidation and the concentration 
after 6 h of oxidation, are presented in Table 5. The loss of 18:1n-9 and 20:4n-6 from LDL PLs 
did not differ among supplement groups. The loss of 18:2n-6 from LDL PLs after FO 
supplementation was 36 nmol/mg LDL protein compared with 57 nmol/ mg LDL protein after 
SA supplementation (P = 0.05) and 56 nmol/mg LDL protein after SU supplementation (P = 
TABLE 5. Specific FA concentrations in LDL PLs and CEs (nmol/mg LDL protein) prior to copper-mediated 
oxidation, after 6 h of oxidation, and the change in concentration after 6 h of oxidation
°
 (N = 15) 
  
Prior 
to Copper-Mediated 
Oxidation 
 After 6 h of 
Oxidation 
  Change After 6 h of 
Oxidation 
 
Sunflower 
Oil 
Safflower 
Oil 
Fish Oil 
Sunflower 
Oil 
Safflower 
Oil 
Fish Oil 
Sunflower 
Oil 
Safflower 
Oil 
Fish Oil 
LDL PLs                   
18:1n-9 131 ± 51 94 ± 62 86 ± 52 145 ± 71 105 ± 72 103 ± 62 14 ± 4 11 ± 6 17 ± 6 
18:2n-6 222 ± 20
1
 238 ± 14
1
 177 ± 13
2
 166 ± 15
1
 182 ± 12
1
 141 ± 13
2
 -56 ± 81,2 -57 ± 8
1
 -36 ± 72 
20:4n-6 95.5 ± 
7.6
1
 
93.4 ± 9.0
1
 76.6 ± 5.7
2
 37.
5 
± 3.8 38.
3 
± 5.8 34.
3 
± 5.0 -55.0 ± 5.2 -55.1 ± 8.3 -42.3 ± 4.4 
20:5n-3 5.4 ± 
0.6
1
 
4.0 ± 0.8
1
 57.5 ± 4.0
2
 0.5 ± 0.4
1
 0.9 ± 0.8
1
 19.
3 
± 2.6
2
 -4.9 ± 0.7
1
 -3.1 ± 1.1
1
 -38.1 ± 
2.9
2
 22:6n-3 25.8 ± 
2.7
1
 
24.2 ± 2.2
1
 58.2 ± 3.7
2
 7.6 ± 1.1
1
 7.9 ± 1.3
1
 18.
2 
± 3.5
2
 -18.2 ± 2.0
1
 -16.3 ± 2.4
1
 -40.0 ± 
4.9
2
 IPUFA
b
 399 ± 29 407 ± 24 416 ± 26 241 ± 20 257 ± 20 46 ± 25 -159 ± 16 -150 ± 18 -171 ± 15 
In-6 
PUFA
c
 
354 ± 26
1
 367 ± 21
1
 275 ± 19
2
 227 ± 18
1
 243 ± 18
1
 194 ± 19
2
 -127 ± 14
1
 -125 ± 16
1
 -82 ± 92 
In-3 
PUFA 
45.3 ± 
4.1
1
 
39.3 ± 3.4
1
 141 ± 10
2
 13.
6 
± 1.9
1
 14.
6 
± 2.1
1
 51.
9 
± 7.4
2
 -31.7 ± 2.9
1
 -24.7 ± 3.2
1
 -89.4 ± 
7.1
2
 PI
d
 774 ± 55
1
 761 ± 50
1
 1,06
5 
± 64
2
 382 ± 33
1
 400 ± 39
1
 491 ± 57
2
 -392 ± 35
1
 -361 ± 43
1
 -574 ± 
482 
CEs 
18:1n-9 
393 ± 21
1
 307 ± 11
2
 317 ± 15
2
 381 ± 28
1
 290 ± 11
2
 302 ± 15
2
 -12 ± 9 -17 ± 9 -16 ± 8 
18:2n-6 964 ± 61
1
 1,14
7 
± 44
2
 932 ± 46
1
 511 ± 46
1
 658 ± 68
2
 611 ± 51
1,2
 -452 ± 
42
1,2
 
-490 ± 54
1
 -321 ± 
372 20:4n-6 142 ± 12 146 ± 16 131 ± 9 33.
5 
± 5.9 44.
9 
± 9.9 48.
5 
± 4.4 -109 ± 6 -101 ± 15 -82.9 ± 8.1 
20:5n-3 10.6 ±1.2
1
 8.6 ± 1.6
1
 134 ± 62 0.6 ± 0.7
1
 0.7 ± 0.6
1
 34.
3 
± 4.7
2
 -10.0 ± 1.2
1
 -8.1 ± 1.5
1
 -99.3 ± 
6.2
2
 22:6n-3 10.4 ± 
2.3
1
 
11.7 ± 1.6
1
 26.5 ± 2.5
2
 NDe,1 3.5 ± 1.6
2
 4.5 ± 1.7
2
 -10.4 ± 2.3
1
 -8.2 ± 2.2
1
 -21.9 ± 
2.9
2
 IPUFA 1,17
0 
± 71
1
 1,34
6 
± 52
2
 1,25
9 
± 
53
1,2
 
556 ± 52
1
 714 ± 78
2
 714 ± 60
2
 -614 ± 47 -632 ±61.7 -545 ± 45 
In-6 
PUFA 
1,12
8 
± 67
1
 1,30
8 
± 51
2
 1,07
2 
± 50
1
 549 ± 51
1
 706 ± 78
2
 665 ± 55
2
 -579 ± 46 
1
 -602 ± 62
1
 -407 ± 
422 In-3 
PUFA 
42.3 ± 
6.1
1
 
38.5 ± 4.8
1
 187 ± 10
2
 7.5 ± 1.7
1
 8.5 ± 1.8
1
 49.
1 
± 7.1
2
 -34.9 ± 4.9
1
 -30.0 ± 5.8
1
 -138 ± 
10
2
 I 1,57
5 
± 99
1
 1,75
4 
± 81
1
 2,07
4 
± 80
2
 635 ± 62
1
 828 ± 
991,2 
955 ± 84
2
 -940 ± 65 -925 ± 88 -119 ± 80 
 
° Values are LSM ± SEM. Different superscript numbers represent significant differences among 
supplement groups (P < 0.05). 
b IPUFA represents the sum of all PUFAs measured in LDL PLs or CEs. 
c In-6 PUFA and In-3 PUFA represent the sums of all n-6 and n-3 PUFAs, respectively, measured in LDL 
PLs or CEs. 
d
 PI represents the peroxidation index for LDL PLs or CEs. 
e ND = not detected. 
 
0.06). The loss of 20:5n-3 from LDL PLs after FO supplementation was 38 nmol/mg LDL 
protein compared with 5 nmol/mg LDL protein after SU supplementation and 3 nmol/mg LDL 
protein after SA supplementation (P < 0.0001 for both comparisons). Loss of 22:6n-3 from LDL 
PLs after FO supplementation was 40 nmol/mg LDL protein compared with 18 nmol/mg LDL 
protein after SU supplementation (P = 0.0003) and 16 nmol/mg LDL protein after SA 
supplementation (P < 0.0001). Loss of 20:5n-3 and 22:6n-3 did not differ between the SU and 
SA supplement groups. 
 
Although the loss of total PUFA from LDL PLs did not differ significantly among supplement 
groups, loss of n-6 PUFA from LDL PLs after FO supplementation was 82 nmol/mg LDL 
protein compared with 127 nmol/mg LDL protein after SU supplementation and 125 nmol/mg 
LDL protein after SA supplementation (P = 0.02 for both comparisons). Loss of n-3 PUFA from 
LDL PLs after FO supplementation was 89 nmol/mg LDL protein compared with 32 nmol/mg 
LDL protein after SU supplementation and 25 nmol/mg LDL after SA supplementation (P < 
0.0001 for both comparisons). However, the fraction of n-6 PUFA lost after 6 h of oxidation was 
about one-third for all three supplement groups, whereas the fraction of n-3 PUFA lost was 
closer to two-thirds for all three supplement groups. At the end of 6 h of oxidation, the PI for 
LDL PLs after FO supplementation was 491 compared with 382 after SU supplementation (P = 
0.01) and 400 for linoleate-enriched LDL PLs (P = 0.04). The PI for LDL PLs decreased by 
approximately 50% after 6 h of oxidation for each supplement group, resulting in a significantly 
greater change after FO supplementation than after SU supplementation (P = 0.01) and SA 
supplementation (P = 0.003). 
 
PUFA content of LDL CEs prior to and after 6 h of oxidation 
FA content of LDL CEs prior to oxidation also reflected the FA consumption during the 
supplement period (Table 5). The 18:1n-9 content of LDL CEs was 86 nmol/mg LDL protein 
higher after SU supplementation than after SA supplementation (P = 0.001) and 76 nmol/mg 
LDL protein higher than after FO supplementation (P = 0.004) . After SA supplementation, the 
18:2n-6 content of LDL CEs was 183 nmol/mg LDL protein higher than after SU 
supplementation (P = 0.009) and 215 nmol/mg LDL protein higher than after FO 
supplementation (P = 0.002). The 20:4n-6 content of LDL CEs did not differ significantly among 
the supplement groups. After FO supplementation, the 20:5n-3 content of LDL CEs was approxi-
mately 125 nmol/mg LDL protein higher than after SU and SA supplementation (P < 0.0001 for 
both comparisons), whereas 22:6n-3 content was 16 nmol/mg LDL protein higher after SU 
supplementation (P = 0.0002) and 15 nmol/mg LDL protein higher than after SA supple-
mentation (P = 0.0004). The PI for LDL CEs was significantly higher after FO supplementation 
than after SU supplementation (P = 0.0007) and SA supplementation (P = 0.02). 
 
Losses of specific FAs from LDL CEs after 6 h of oxidation are also presented in Table 5. The 
loss of 18:2n-6 from LDL CEs after SA supplementation was 490 nmol/ mg LDL protein 
compared to only 321 nmol/mg LDL protein after FO supplementation (P = 0.04). The loss of 
20:5n-3 from LDL CEs after FO supplementation was 99 nmol/mg LDL protein compared with 
10 nmol/mg LDL protein after SU supplementation and 8 nmol/mg LDL protein after SA 
supplementation (P = 0.0001 for both comparisons). Loss of 22:6n-3 LDL CEs was 22 nmol/mg 
LDL protein after FO supplementation compared with 10 nmol/mg LDL protein after SU 
supplementation (P = 0.02) and 8 nmol/mg LDL protein after SA supplementation (P = 0.004). 
 
Although the loss of total PUFA from LDL CEs did not differ significantly among supplement 
groups, loss of n-6 PUFA from LDL CEs after FO supplementation was 407 nmol/mg LDL 
protein compared with 579 nmol/mg LDL protein after SU supplementation (P = 0.04) and 602 
nmol/mg LDL protein after SA supplementation (P = 0.02). Loss of n-3 PUFA from LDL CEs 
after FO supplementation was 138 nmol/mg LDL protein compared with 35 nmol/mg LDL 
protein after SU supplementation and 30 nmol/mg LDL protein after SA supplementation (P < 
0.0001 for both comparisons). As in LDL PLs, the fraction of n-3 PUFA (69–84%) lost after 6 h 
of oxidation was greater than that of n-6 PUFA (38–52%). At the end of 6 h of oxidation, the PI 
for LDL CEs decreased by approximately 55% in each supplement group. 
 
LDL α-tocopherol depletion 
When normalized to LDL protein (Fig. 1A), initial LDL α-tocopherol concentrations did not 
differ among supplement groups. After 10 min of CuSO4-mediated oxidation, FO-supplemented 
LDL contained less than half of the α-tocopherol found in SU- and SA-supplemented LDL (P < 
0.0001 for both comparisons). After 20 min of oxidation, the mean α-tocopherol concentration in 
FO-supplemented LDL was 10 times less than that of SU-supplemented LDL (P = 0.0003), 
wheareas SA-supplemented LDL contained less than half that of SU-supplemented LDL (P = 
0.05). The rate of loss of α-tocopherol (data not shown) during CuSO4-mediated oxidation from 
SU-supplemented LDL was 32% slower than from SA-supplemented LDL (P = 0.04) and 48% 
slower than from FO-supplemented LDL (P = 0.002). The rate of α-tocopherol loss from SA- 
and FO-supplemented LDL did not differ significantly. The estimated time of α-tocopherol 
depletion of LDL during oxidation (data not shown) from FO-supplemented LDL was 16 min 
compared with 26 min for SU-supplemented LDL (P < 0.0001) and 20 min for SA-supplemented 
LDL (P = 0.05). The difference between SU- and SA-supplemented LDL was also statistically 
significant (P = 0.002). 
 
Because LDL lipid content differed between supplement groups, α-tocopherol concentrations 
were also normalized to LDL lipid content (Fig. 1B). When α-tocopherol concentrations were so 
normalized, differences among supplement groups prior to oxidation remained nonsignificant. 
After normalization to LDL lipid content, α-tocopherol 
 
Fig. 1. Loss of a-tocopherol from LDL during copper-mediated oxidation. A: 
Mean LDL a-tocopherol concentrations at 0, 10, and 20 min of copper-mediated 
oxidation. Data points represent LDL a-tocopherol concentrations, normalized to 
LDL protein content, after supplementation of the diets of 15 postmenopausal 
women with high oleate SU (squares), high linoleate SA (circles), and FO 
(triangles). Values are LSM ± SEM. Different letters represent significant 
differences among supplement groups (P < 0.05). B: Mean LDL atocopherol 
concentrations at 0, 10, and 20 min of copper-mediated oxidation, normalized to 
LDL total lipid content. 
concentrations at 10 min of oxidation were significantly lower in SA-supplemented LDL than 
SU-supplemented LDL (P = 0.05), and at 20 min of oxidation the difference between SA- and 
SU-supplemented LDL was no longer statistically significant. 
 
PCOOH formation during LDL oxidation 
The formation of lipid hydroperoxides in LDL subjected to CuSO4-mediated oxidation was 
evaluated using several different measurements: 1) the length of the lag phase, 2) the time to 
one-half maximal concentration of hydroperoxides, 3) the maximal rate of hydroperoxide 
formation during the propagation phase, and 4) the maximal concentration of hydroperoxides. 
The oxidative susceptibility of LDL as determined by measuring the production of PCOOH and 
CE18:2OOH are presented together in Fig. 2. The duration of the lag phase in the production of 
PCOOH during CuSO4- mediated oxidation was significantly shorter after FO supplementation 
than after SU and SA supplementation. Mean lag phase duration after FO supplementation was 
27 min less than after SU supplementation (P < 0.0001) and nearly 18 min less than after SA 
supplementation (P = 0.006). The time required to reach half of the maximal concentration of 
PCOOH after SU supplementation was 46 min longer than after FO supplementation (P = 
0.003). The maximal rate of PCOOH formation during the propagation phase of LDL oxidation 
was 39% more rapid after SA supplementation than after FO supplementation (P = 0.02). The 
maximal concentration of PCOOH during CuSO4-mediated LDL oxidation was 28% lower after 
FO supplementation than after SA supplementation (P = 0.03). Normalization of the maximal 
rates and maximal concentrations of PCOOH to LDL PC concentrations did not change the 
above results. 
 
CE18:2OOH formation during LDL oxidation 
Even in LDL enriched with SU or FO, CE18:2n-6 accounted for more than 40% of the CE 
fraction. During copper-mediated oxidation, CE18:2OOH accounted for more than 80% of the 
hydroperoxides that could be quantified using the HPLC/chemiluminescence procedure de-
scribed above. Only CE18:2OOH could be detected in sufficient quantities at all time points to 
allow for the plotting of kinetic curves. For these reasons, CE18:2OOH concentrations were used 
to assess the oxidative susceptibility of LDL CEs and are presented in Fig. 2. The duration of the 
lag phase in the production of CE18:2OOH during CuSO4-mediated oxidation was nearly 18 
min longer after SU supplementation than after FO supplementation (P = 0.03) but did not differ 
significantly between SA and FO. The time required to reach half of the maximal concentration 
of CE18:2OOH was statistically equivalent after all supplements. The maximal rate of 
CE18:2OOH formation during the propagation phase of LDL oxidation was 31% more rapid 
after SA supplementation than after SU supplementation (P = 0.03) and 76% more rapid than 
after FO supplementation (P < 0.0001). The maximal concentration of CE18:2OOH during 
CuSO4-mediated LDL oxidation was 30% lower after FO supplementation than after SU 
supplementation (P = 0.04) and 49% lower than after SA supplementation (P = 0.0006). 
Normalization of maximal rates and maximal concentrations of CE18:2OOH to LDL cholesteryl 
linoleate concentrations eliminated any statistically significant differences among the three 
supplement groups. 
 
Hydroperoxide formation from CEs of specific FAs 
Calculation of the parameters of LDL oxidative susceptibility discussed above using the sum of 
all CEOOH species measured (CE18:2OOH, CE20:4OOH, CE18:1OOH, and CE22:6OOH) did 
not result in any significant changes in the results obtained by using only the CE18:2OOH 
values. The proportions of the maximal concentration of CEOOH, during 6 h of LDL oxidation, 
contributed by the hydroperoxides of CEs of specific FAs are presented in Table 6. Maximal 
CE18:1OOH concentrations were 23% higher after SU supplementation than after SA 
supplementation (P = 0.03) and 92% higher than after FO supplementation (P < 0.0001), whereas 
maximal CE18:1OOH concentrations were 56% higher after SA supplementation than after FO 
supplementation (P = 0.02). Maximal CE18:2OOH concentrations are reviewed in the previous 
section and in Fig. 3B. Maximal CE20:4OOH concentrations were 82% higher after SU 
supplementation than after FO supplementation (P = 0.0003) and 121 % higher after SA sup-
plementation than after FO supplementation (P < 0.0001). Maximal CE22:6OOH concentrations 
were more than 4.5 times higher after FO supplementation than after SU and SA 
supplementation (P < 0.0001 for both comparisons), the results obtained by using only the 
CE18:2OOH values. The proportions of the maximal concentration of CEOOH, during 6 h of 
LDL oxidation, contributed by the hydroperoxides of CEs of specific FAs are presented in Table 
6. Maximal CE18:1OOH concentrations were 23% higher after SU supplementation than after 
SA supplementation (P = 0.03) and 92% higher than after FO supplementation (P < 0.0001), 
whereas maximal CE18:1OOH concentrations were 56% higher after SA supplementation than 
after FO supplementation (P = 0.02). Maximal CE18:2OOH concentrations are reviewed in the 
previous section and in Fig. 3B. Maximal CE20:4OOH concentrations were 82% higher after SU 
supplementation than after FO supplementation (P = 0.0003) and 121 % higher after SA sup-
plementation than after FO supplementation (P < 0.0001). Maximal CE22:6OOH concentrations 
were more than 4.5 times higher after FO supplementation than after SU and SA 
supplementation (P < 0.0001 for both comparisons), 
Fig. 2. Susceptibility of LDL surface and core lipids to copper-mediated oxidation assessed by the formation 
of PCOOH and CE18:2OOH. A: The duration of the lag time, B: The time to reach one-half of the maximal 
concentration of hydro- peroxides, (C) the maximal rate of hydroperoxide formation, and (D) the maximal 
concentration of hydroperoxides. Bars with different letters over them represent significant differences 
among groups after 5 weeks of supplementation of the diets of 15 postmenopausal women with 15 g/day of 
high oleate SU (diagonally striped bars), high linoleate SA (solid bars), and FO (white bars) (P < 0.05). 
 
 
TABLE 6. Maximal concentrations of hydroperoxides of specific  
CEs (nmol/mg LDL protein) measured during CuSO4-mediated  
oxidation of LDL after supplementation with oleate-rich  
SU, linoleate-rich SA, and FO
a
 (N = 15) 
CEOOH 
Sunflower 
Oil 
Safflower Oil Fish Oil 
   nmol/mg LDL 
protein 
  
CE18:1OOH 5.8 ± 0.3
1
 4.7 ± 0.6
1
 3.0 ± 0.6
2
 
CE18:2OOH 66.8 ± 3.7
1
 76.6 ± 4.6
1
 51.4 ± 
3.82 
CE20:4OOH 4.8 ± 0.3
1
 5.8 ± 0.6
1
 2.7 ± 
0.22 
CE22:6OOH 0.7 ± 0.2
1
 0.7 ± 0.1
1
 3.8 ± 
0.32 
Sum CEOOH 76.4 ± 3.9
1
 86.3 ± 5.4
1
 58.3 ± 
4.22 
a Values are LSM ± SEM. Different superscript numbers represent significant differences among 
supplement groups (P _- 0.05). though they were still much lower than CE18:2OOH concentrations after all 
three supplements. 
 
Loss of LDL α-tocopherol during oxidation and the lag phase for hydroperoxide formation 
Examination of the relationship between the loss of α-tocopherol and the formation of PCOOH 
in oxidizing LDL (Fig. 3A) revealed that, on average, significant PCOOH formation occurred 
before LDL was depleted of α-tocopherol in all three supplement groups. After FO 
supplementation, LDL was depleted of α-tocopherol more rapidly than after SU supplementation 
(P = 0.0001) and after SA supplementation (P = 0.05). Unlike SU- and SA-supplemented LDL, 
the most rapid rate of PCOOH formation in FO-supplemented LDL was observed between 0 and 
20 min of oxidation. Once FO-supplemented LDL was depleted of α-tocopherol, the rate of 
PCOOH formation slowed. 
 
When CE18:2OOH formation was examined with respect to LDL α-tocopherol depletion (Fig. 
3B), a distinct lag phase, propagation phase, and plateau could be identified. Unlike PCOOH 
formation, the propagation phase (maximal rate) for CE18:2OOH formation did not begin until 
LDL had been depleted ofα-tocopherol in each of the supplement groups. Note that althoughα-
tocopherol was lost most rapidly from FO-supplemented LDL, the rate of CE18:2OOH 
formation in FO-supplemented LDL was slowest. 
 
DISCUSSION 
The purpose of the present study was to determine whether increased consumption of FO 
containing highly 
 
Fig. 3. The relationship between α-tocopherol loss and lipid hydroperoxide 
formation during copper- mediated LDL oxidation. A: α-Tocopherol 
concentrations with respect to PCOOH concentrations in oxidizing LDL; values 
are mean ± SEM. Loss of α-tocopherol is represented by solid circles, and 
formation of PCOOH is represented by open squares at the end of 
supplementation of the diets of 15 postmenopausal women with 15 g/day of oil 
high oleate SU (top graph), high linoleate SA (middle graph), and FO (bottom 
graph). B: α-Tocopherol concentrations with respect to CE18:2OOH 
concentrations in oxidizing LDL. Loss of α-tocopherol is represented by solid 
circles, and formation of CEOOH is represented by open squares at the end of 
supplementation of the diets of 15 postmenopausal women with 15 g/day of oil 
high oleate SU (top graph), high linoleate SA (middle graph), and FO (bottom 
graph). 
unsaturated n-3 PUFA increased LDL susceptibility ex vivo oxidation, as compared with the 
consumption of dietary oils rich in n-6 PUFA (SA) and MUFA (SU) by healthy postmenopausal 
women. Although the loss of n-6 PUFA from LDL PLs and CEs was lower and the loss of n-3 
PUFA greater after FO supplementation than after SU and SA supplementation, the loss of total 
PUFA did not differ among the three supplement groups. In each supplement group the fraction 
of n-3 PUFA lost from LDL PLs and CEs was almost twice as high as that of n-6 PUFA, 
suggesting that n-3 PUFA are more susceptible to oxidation than are n-6 PUFA. However, the 
extent of oxidation of LDL core and surface lipids, as indicated by the loss of total PUFA from 
LDL PLs and CEs after 6 h of oxidation, was not significantly greater after FO supplementation. 
 
In our attempt to follow the oxidation of specific CEs in the hydrophobic core of LDL, only 
CE18:2OOH could be detected in sufficient quantities at all time points to calculate lag time and 
rate of CEOOH formation. EPA, the n-3 PUFA found in highest concentrations in LDL CE after 
FO supplementation, could not be accurately measured. As expected, the maximal rate of 
CE18:2OOH formation was most rapid after SA supplementation, but maximal concentrations 
of CE18:2OOH were lowest after FO supplementation. The lag phase for the formation of 
CE18:2OOH was shorter after FO supplementation than after SU supplementation, but did not 
differ from the lag phase after SA supplementation, suggesting that core lipid oxidation may be 
initially more rapid in n-3 PUFA-enriched LDL than in MUFA- enriched LDL, but not different 
than in n-6 PUFA-enriched LDL. Although the assessment of CE18:2OOH formation in the 
present study did not provide a measure of total lipid peroxidation within the LDL core, the 
results indicated that FO supplementation did not shorten the lag time or increase the rate of 
CE18:2OOH formation compared with SA supplementation. 
 
The measurement of total PCOOH formation during LDL oxidation offers a more global 
assessment of the oxidation of LDL surface lipids than the CEOOH assay did for core lipids. 
The lag time for PCOOH formation was significantly shorter after FO supplementation than 
after SU and SA supplementation, suggesting that oxidation of LDL surface lipids was more 
rapid after FO supplementation than after SU and SA supplementation. However, the 
maximal rate of PCOOH formation and the maximal concentration of PCOOH were lower after 
FO supplementation than after SU supplementation. These data could indicate that LDL surface 
lipids are initially more readily oxidized in LDL supplemented with FO but that the extent of 
oxidation is not greater in LDL supplemented with FO compared with SA. Although the 
decreased rate and maximal concentration observed in LDL supplemented with FO could be due 
to more rapid decomposition of hydroperoxides derived from n-3 PUFA, other mechanisms 
could also explain these findings. 
 
Studies of aqueous micelles have suggested that the presence of highly unsaturated n-3 PUFA 
might actually decrease total lipid peroxidation in vitro. Investigations by Yazu et al. (7, 45) 
demonstrated that the presence of methyl esters of EPA and linoleate in a 1:1 ratio in aqueous 
micelles reduced the oxidation of total substrate (EPA and linoleate) 5-fold compared with 
micelles of linoleate alone. Their results indicated that linoleate formed mainly hydroperoxides 
containing one molecule of O2, whereas EPA formed mainly bicycloendoperoxides containing 
two molecules of O2. The increased polarity of EPA-derived peroxyl radicals appeared to 
enhance their diffusion to the micelle surface, increasing the termination reaction rate, 
decreasing the propagation rate, and ultimately decreasing the rate of total substrate oxidation in 
the EPA/ linoleate micelles. 
The LDL particle consists of an amphipathic surface monolayer and a hydrophobic core, 
suggesting it may behave more like the biphasic system of the aqueous micelle than like 
homogeneous solutions of fatty esters. Moreover, a number of FAs with three or more double 
bonds have been found to form bicyclocendoperoxyl radicals (46). Therefore, in FO-
supplemented LDL, the highly unsaturated n-3 FAs might also form more polar radicals, which 
would be more likely to localize at the surface of LDL particles, resulting in an increased rate of 
termination and a slower propagation rate. 
The loss of LDL α-tocopherol during copper-mediated oxidation was most rapid after FO 
supplementation, occurring in approximately 16 min rather than 19 and 26 min after SA and SU 
supplementation, respectively. Examination of the lag time for PCOOH formation and the loss 
of LDL α-tocopherol during copper-mediated oxidation revealed that the propagation phase of 
PCOOH formation began prior to the depletion of α-tocopherol from LDL. This phenomenon 
was most dramatic after FO supplementation, where the rate of PCOOH formation was greatest 
during the first 20 min of copper-mediated oxidation. With FO supplementation, the rate of 
PCOOH formation slowed once the LDL particle was depleted of α-tocopherol. These data 
suggest that increasing the content of highly unsaturated n-3 PUFA in LDL PLs resulted in more 
rapid consumption of LDL α-tocopherol. The lower rate of PCOOH formation and lower 
maximal concentration of PCOOH in n-3 PUFA-enriched LDL could be explained by 
tocopherol-mediated peroxidation (TMP). During TMP, α-tocopherol is the primary lipid 
peroxidation chain-carrying radical when present in the LDL particle (47). Under relatively mild 
oxidizing conditions (-5 mol Cu
²+
/mol LDL in the present study), the rate of lipid hydro- 
peroxide formation is increased when LDL is supplemented with α-tocopherol and decreased 
when LDL is depleted of α-tocopherol. Thus, using the TMP model, the decreased rate of 
PCOOH formation and the lower maximal PCOOH concentrations found after FO 
supplementation could be explained by the relatively rapid depletion of α-tocopherol from LDL 
enriched with n-3 PUFA. 
In the present study, the only parameters suggesting increased oxidative susceptibility in LDL 
supplemented with FO compared with SA were the shorter lag time in PCOOH formation and 
the more rapid loss of α-tocopherol. Although these findings likely reflect the increased oxida-
tive susceptibility of n-3 FAs, the finding that hydroperoxide formation and loss of total PUFA 
were not greater in LDL supplemented with FO compared with SA leaves open the possibility 
that overall, total oxidation of the LDL particle was not increased by FO supplementation. 
A number of studies have shown the consumption of fish to be associated with decreased 
mortality from cardiovascular disease (48–50). The mechanisms for the observed 
cardioprotective effects of increased fish consumption are not yet clear. On the basis of the 
results of this study, the beneficial effects of increased fish consumption do not appear to be 
significantly offset by an increase in the oxidative susceptibility of LDL. However, these 
conclusions depend on the assumption that resistance to copper-mediated oxidation ex vivo 
reflects decreased oxidative susceptibility in vivo. Whether the oxidation of LDL enriched with 
n-3 PUFA behaves similarly under more physiologically relevant oxidizing conditions remains 
to be studied. 
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